MENU
ABOUT US
MAKE A DONATION
Login
SEARCH
CLOSE
Help Center
subscribe
newsletter
Newsstands
Epoch Shop
Gift
TOP NEWS
SPECIAL SERIES
SPECIAL COVERAGE
LATEST ARTICLES
US
US News
US Features
US Politics
US Crime News
New York
San Francisco
Los Angeles
Opinion
Thinking About China
Viewpoints
Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
The Reader’s Turn
China News
US-China Relations
Chinese Regime
Business & Economy
Chinese Culture
China Human Rights
Social Issues
Organ Harvesting in China
World News
Africa News
Americas
Asia & Pacific
Canada
Europe
UK News
Australia News
International
Middle East
Business & Markets
Companies
Economy
Markets
Real Estate
Gold and Commodities
ARTS & CULTURE
Fine Arts & Craftsmanship
Performing Arts
Books
Traditional Culture
Shen Yun Special Coverage
Film & TV
Science
News
Space
Environment
Tech
Tech News
Tech Products & Reviews
Social Media
Sports
Videos
American Thought Leaders
China Insider
Crossroads
Bright
Lifestyle
Inspired
Family & Education
Personal Finance
American Essence
Entertainment
Film & TV
Entertainment News
Health
Experts
Conditions
Life & Wellness
Special Topics
Battlefields
Search Text
SEARCH
EpochTV
US
US Politics
Opinion
World News
China
Hong Kong
Health
Bright
Arts
Falun Gong
Premium
Markets
Games
Livestream
More
Mounjaro
Over 700 Drugs More Expensive in 2024, Including Ozempic and Mounjaro
To start 2024, prices hikes on hundreds of drugs are up 22 percent, but record cost savings are expected for Medicaid
January 22, 2024
BY
A.C. Dahnke
Eli Lilly to Sell Weight Loss Drugs Directly to Patients
The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
January 8, 2024
BY
A.C. Dahnke
FDA Investigating Reports of Alopecia and Suicidal Ideation as Possible Weight-Loss Drug Side Effects
The FDA is also investigating reported side effects of aspiration.
January 4, 2024
BY
A.C. Dahnke
How Effective is Weight-Loss Medication vs. Supplements? New Phase of Weight-Loss Meds | Feat. Dr. Damon Noto
Dr. Damon Noto discusses the pros and cons of weight loss drugs Ozempic and Mounjaro on VitalSigns.
October 20, 2023
BY
Brendon Fallon
Diabetes Drug Manufacturers Sued by Woman Who Claims She Suffered ‘Severe Gastrointestinal Events’
The manufacturers of diabetes drugs Ozempic and Mounjaro have been sued by a Louisiana woman who claims they failed to adequately ...
August 3, 2023
BY
Katabella Roberts
UK Public Agency Won’t Recommend Weight Loss Drug Mounjaro, Needs More Evidence
UK's health and social care watchdog has decided against recommending Mounjaro, Eli Lilly's weight loss drug for adults with diabetes. ...
June 28, 2023
BY
Harry Lee
Diabetes Drug Shown to Effectively Trim Fat With Minimal Muscle Loss: Study
Based on a recent analysis, Mounjaro, an approved medication for Type 2 diabetes, has shown promise in reducing ...
May 31, 2023
BY
Harry Lee
TOP NEWS
Thousands of Travelers Still Stranded After FAA Lifts Nationwide Ground Stop
NEW
By
Tom Ozimek
In Charts: Obamacare Premiums to Increase Again
NEW
By
Sylvia Xu
Trump Extends Jones Act Waiver 90 Days With No Lapse, White House Says
2hr
By
Kimberly Hayek
US Designates 3 Guatemalan Drug Clans as Terrorists Over Cartel Ties
3hr
By
Kimberly Hayek
What to Know About the FAA’s Decision to Ground Flights Nationwide
4hr
By
Jeremy Lott
The Last of the Greek Boatbuilders
4hr
By
Beige Luciano-Adams
US Air Force Responds to Suspected Drone Activity at UK Airbase
9hr
By
Aldgra Fredly
SpaceX Sends 2nd Starship Into Orbit, Aborts Booster Catch at Launchpad
11hr
By
T.J. Muscaro
Jensen Huang Scandal Puts Spotlight on National Security Concerns Over Nvidia’s AI Chips
12hr
By
Andrew Moran
Flávio Bolsonaro on His Escape, the Election, and His Plans for a Comeback
12hr
By
Jan Jekielek
, Epoch TV